Dr. Amy McMichael highlighted the clinical presentation of alopecia areata, describing the characteristic patchy, round hair ...

Adhering to the current guideline standard for intraoperative nodal assessment in resected non–small cell lung cancer (NSCLC) ...

Shields and Baptist Health established an integrated specialty pharmacy at Baptist MD Anderson Cancer Center to embed medication access services within clinical workflows and the health system’s ...

Indication expansion now includes CAR‑T–associated severe or life-threatening CRS for adults and pediatric patients aged ≥2 years, supporting guideline-concordant IL‑6 receptor blockade in ...

Arash Mostaghimi highlighted the scientific journey that led to Janus kinase (JAK) inhibitors becoming a treatment avenue for alopecia areata, beginning with a case report by Brett King in which a ...

Real-world diabetic macular edema care lags trials as fewer VEGF injections and step therapy limit outcomes. Persistent ...

State data reveal 2026 ACA marketplace enrollment losses are accelerating post open enrollment, as cancellations surge and ...

Alopecia areata affects ~2% globally and is associated with atopic/autoimmune overlap, psychological comorbidity, and a ...

Kerry Rogers, MD, examines the underemphasized BTK inhibitor adverse effects that quietly erode patient quality of life—and ...

A 546-patient, multicountry phase 3 trial randomized participants on insulin glargine (± metformin/SGLT2 inhibitors) to ...

The Medicare GLP-1 Bridge's July 1 launch is now the only concrete milestone on the calendar. Whether it becomes the ...

Influenza vaccine coverage increased 7.4% from 2017-2018 to 2019-2020, then fell 12.9% from 2019-2020 to 2022-2023 in this ...